Analgesic Effects of Vilazodone, Indatraline, and Talsupram in a Rat Model of Neuropathic Pain
- 27 June 2022
- journal article
- research article
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 19 (3), 336-342
- https://doi.org/10.4274/tjps.galenos.2021.41514
Abstract
Objectives: Drugs that inhibit the reuptake of serotonin, norepinephrine, and/or dopamine are widely used for treating depressive disorders and have emerged as effective drugs for neuropathic pain. They have no substantial anti-nociceptive effects but are considered, with gabapentin/ pregabalin, first-line drugs for neuropathic pain. Materials and Methods: In this study, three different antidepressant agents were used in different doses to investigate their anti-hyperalgesic effects in rat models of neuropathic pain using hot plate and tail flick methods. They have different mechanisms of action; vilazodone hydrochloride is a selective serotonin inhibitor and a 5-HT1A partial agonist; talsupram hydrochloride is a selective noradrenaline inhibitor, and it has a high affinity for noradrenaline transporter (NET), whereas indatraline hydrochloride is a triple reuptake inhibitor that inhibits transporters for 5-HT (SERT), dopamine (DAT), and NET. Results: All the drugs used in the experiment were found to have an anti-hyperalgesic effect in both tests compared to the sham group. When antihyperalgesic effects of the three agents were compared to each other, it was found that talsupram hydrochloride was significantly more effective than the two other drugs in hot plate test. However, there was no statistically significant difference in the tail flick test. Indatraline hydrochloride was more effective than vilazodone hydrochloride at the same doses in the tail flick test. Conclusion: Our data suggest that three drugs are effective analgesics in rat models of neuropathic pain and inhibition of noradrenaline reuptake represents the cornerstone of analgesic mechanisms of effective antidepressants.Keywords
This publication has 41 references indexed in Scilit:
- The evidence for pharmacological treatment of neuropathic painPain, 2010
- EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEuropean Journal of Neurology, 2010
- Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension StudyPain Medicine, 2010
- The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorderCurrent Medical Research and Opinion, 2008
- Models of Nociception: Hot‐Plate, Tail‐Flick, and Formalin Tests in RodentsCurrent Protocols in Neuroscience, 2007
- The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population SurveyThe Journal of Pain, 2006
- Descending control of painProgress in Neurobiology, 2002
- The Efficacy of Selective Serotonin Reuptake Inhibitors for the Management of Chronic PainJournal of General Internal Medicine, 1997
- Endotoxin-induced local inflammation and hyperalgesia in rats and mice: a new model for inflammatory painPain, 1996
- A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injuryPain, 1990